What sectors does Boehringer Ingelheim Venture Fund invest in?

Evergreen corporate venture fund of Boehringer Ingelheim. Invests in early-stage biotech startups in oncology, regenerative medicine, infectious diseases, and digital health.

Typical check size

€1M – €15M

Fund size: €350M (evergreen)

Browse similar check sizes →

Portfolio highlights

Aignostics - AI-powered pathology diagnostics

Tacalyx - immuno-oncology targeting tumor glycans

Abalos Therapeutics - oncolytic virus immunotherapies

Contact

boehringer-ingelheim-venture.com

Germany

Research with AI

Learn more about Boehringer Ingelheim Venture Fund using AI:

Ask ChatGPT Ask Perplexity

Pitch guides

Learn what Boehringer Ingelheim Venture Fund and similar investors look for:

Biotech pitch guide Healthtech pitch guide

More investors in Germany

10x Founders 10x Group 1750 Ventures 3B Future Health Fund View all in Germany

Related resources

Seed fundraising guide Seed pitch deck guide Series A fundraising guide Series A pitch deck guide Glossary: Term sheet Glossary: Cap table

Fundraising in Germany

Tips, programs, and cultural notes

More Biotech investors

5AM Ventures 5Y Capital a16z Bio Abingworth View all Biotech investors

Ready to start fundraising?

Create your pitch deck with AI, get investor-ready feedback, and find the right investors for your startup.

Get started free

Corporate VC

Germany

Boehringer Ingelheim Venture Fund

Investment focus

Sectors

Biotech

Life Sciences

Healthtech

Investment stages

Seed

Series A

Geographic focus

Europe

Global

Investment thesis

Evergreen corporate venture fund of Boehringer Ingelheim. Invests in early-stage biotech startups in oncology, regenerative medicine, infectious diseases, and digital health.